ROSETTA CAPITAL
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments. Rosetta Capital Limited is based in London, United Kingdom.
ROSETTA CAPITAL
Status:
Active
Contact:
+44 (0) 1844 291 444
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics WordPress Google Universal Analytics Font Awesome Apache Wordpress Plugins
Similar Organizations
AIF Capital
AIF Capital Limited is a private equity and venture capital firm specializing in middle market
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-09-20 | Asarina Pharma | Rosetta Capital investment in Post-IPO Equity - Asarina Pharma | 150 M SEK |
| 2017-02-20 | Modus Therapeutics | Rosetta Capital investment in Venture Round - Modus Therapeutics | 32 M SEK |
| 2016-09-27 | Dilafor | Rosetta Capital investment in Venture Round - Dilafor | 51 M SEK |
| 2014-02-17 | NovImmune | Rosetta Capital investment in Series B - NovImmune | 66 M USD |
| 2013-03-08 | Asarina Pharma | Rosetta Capital investment in Venture Round - Asarina Pharma | N/A |
| 2013-02-13 | Biosergen AS | Rosetta Capital investment in Funding Round - Biosergen AS | N/A |
| 2013-01-01 | Aprea | Rosetta Capital investment in Series A - Aprea | N/A |
| 2010-10-11 | MerLion Pharma | Rosetta Capital investment in Series C - MerLion Pharma | 7 M USD |
| 2006-02-10 | EyeSense AG | Rosetta Capital investment in Series A - EyeSense AG | 10.7 M CHF |
More informations about "Rosetta Capital"
Rosetta Capital – Life Sciences Venture Investments
Rosetta is a venture capital firm focused on the life sciences and medical device sectors. We are commited to transforming healthcare through our investments.See details»
About us - Rosetta Capital
Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Our investment approach is global, building leading healthcare companies and groundbreaking technologies with the …See details»
Rosetta Capital - Crunchbase Investor Profile
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments. Rosetta Capital Limited is based in London, United Kingdom.See details»
Rosetta Capital Corporation
Rosetta Capital is a private equity investment firm based in Pittsburgh, PA that acquires and invests in companies with values from $5 million to $50 million. Rosetta’s partners have …See details»
Rosetta Capital - LinkedIn
Rosetta is a specialised UK-based venture capital firm focused on the life sciences and medical device sectors. Our investment approach is global, building leading healthcare companies...See details»
Our portfolio - Rosetta Capital
Nov 15, 2022 · We are a specialist UK-based life science venture capital firm that invests globally to build leading healthcare companies and breakthrough technologies that can deliver benefits …See details»
Rosetta Capital Corporation - Crunchbase
Rosetta Capital is a private equity investment firm based in Pittsburgh, PA that acquires and invests in companies with values from $5 million to $50 million. Rosetta’s partners have successful track records in owning and growing …See details»
Rosetta Capital (UK) Investor Profile: Portfolio & Exits
Founded in 2001, Rosetta Capital is a venture capital firm based in Haddenham, United Kingdom. The firm prefers to invest through direct secondary transactions in companies operating in the life science, healthcare, medical devices, and …See details»
Rosetta Capital - Investments, Portfolio & Company Exits
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments.See details»
About us - Rosetta Capital
We have purchased companies through brokers, from highly sophisticated sellers with teams of lawyers, and from moms and pops who started from scratch. We know how to perform due …See details»
Rosetta Capital Investor Profile: Portfolio & Exits
Founded in 1970, Rosetta Capital is a private equity investment firm based in Pittsburgh, Pennsylvania. The firm seeks to invest in media, wireless communication, marketing, healthcare, electronic monitoring, manufacturing, …See details»
Our focus – Rosetta Capital
We are a specialist UK-based life sciences venture capital firm that invests globally to build leading healthcare companies and breakthrough technologies that can deliver benefits to …See details»
Meet our Team - Rosetta Capital
From 1999 to 2008, Mr. Wright was Vice President and General Counsel of Business Records Management, and became President of Rosetta Capital in 2004. He currently serves on the …See details»
Rosetta Capital Corp - Company Profile and News
Rosetta Capital Corp operates as a private equity investment firm. The Company invest in storage, transportation, distribution services, health care, and consumer products sectors.See details»
Rosetta Capital - Funding, Financials, Valuation & Investors
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments.See details»
Rosetta Capital IV: Fund Performance - PitchBook
Mar 15, 2013 · Information on investments, limited partners, investment strategy, team and returns for Rosetta Capital IV. Use the PitchBook Platform to explore the full profile.See details»
Revelation Partners is Lead Investor Backing Rosetta Capital to ...
Mar 30, 2021 · Revelation Partners and other investors capitalized Rosetta Capital VI with over £85.0 million, providing sufficient capital to support the portfolio moving forward.See details»
Rosetta Capital VII: Fund Performance - PitchBook
Information on investments, limited partners, investment strategy, and returns for Rosetta Capital VII. Use the PitchBook Platform to explore the full profile.See details»
Jonathan Hepple - Founder & Director @ Rosetta Capital
Jonathan Hepple is the current Non-Executive Director of Nucleome Therapeutics. He previously worked at BioScience Managers Limited as a Founder and Director. Jonathan attended the …See details»
Ken MacLeod - Rosetta Capital
Kenneth Macleod joined Rosetta Capital in 2021 as a Partner. Ken has over 35 years experience in the life sciences sector through senior operating roles in healthcare companies (Abbott …See details»